The epigenetic hallmarks of immune cells in cancer
Abstract Targeting the dysregulation of epigenetic mechanisms in cancer has emerged as a promising therapeutic strategy. Although the significant rationale progress of epigenetic therapies in blocking cancer cells, how epigenetic regulation shapes tumor microenvironment (TME) and establishes antitum...
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
BMC
2025-03-01
|
| Saila: | Molecular Cancer |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12943-025-02255-4 |